Udit Batra is Chief Executive Officer of MilliporeSigma
, the €6 billion Life Science business of Merck KGaA, Darmstadt, Germany and a member of its Executive Board — the first American to hold this position in the company’s 350-year history. In addition to leading MilliporeSigma, Udit has board responsibility for the company’s global Business Technology function.
An immigrant from New Delhi, India, Udit is an accomplished executive who has dedicated his career to improving health for people globally, bringing more than 20 years’ experience in healthcare and the life sciences. Since becoming CEO in 2014, he and his MilliporeSigma team have developed and executed a growth strategy that included the 2015 acquisition of chemicals and technology giant Sigma-Aldrich. Udit architected and led this merger — the largest acquisition in the history of Merck KGaA, Darmstadt, Germany — and one of the largest ever in the life science industry.
Today, Udit continues to lead the business through a strategic transformation that has made MilliporeSigma a top three player in the industry and an employer of choice in many regions where it operates around the world.
MilliporeSigma was named to The Boston Globe's annual "Top Places to Work" list in 2016 and 2017, and received an exclusive certification as a top employer in North America by the independent Top Employers Institute in 2018 for the second year in a row. Also under Udit’s leadership, MilliporeSigma has earned several prestigious awards for innovation, including the R&D 100 Award
for Top Innovations in 2016; a Life Science Industry Award
by BioInformatics in 2016; and a R&D 100 Award
for Corporate Responsibility in 2017.
Udit has earned a well-deserved reputation for driving business growth and turnarounds as well as building high-performing teams. Previously, he led the company’s global Consumer Health business, where his team more than doubled the profitability of the business, making it the fastest growing sector within Merck KGaA, Darmstadt, Germany.
Prior to Merck KGaA, Darmstadt, Germany, Udit served in a range of leadership positions at Novartis, a Swiss multinational pharmaceutical company. In addition to leading Corporate Strategy and Global Public Health and Market Access for Vaccines and Diagnostics, he also served as president of the Australia Pharma business. During his tenure, this subsidiary became the fastest growing business within Novartis. Earlier in his career, Udit held senior positions in the healthcare, consumer and non-profit practices at McKinsey & Company, a global strategy and consulting company.
A chemical engineer by training, Udit earned a bachelor of science degree from the University of Delaware and a doctor of philosophy degree (Ph.D.) from Princeton University. He started his career as a research engineer fellow at Merck & Co, Inc., Kenilworth, NJ, where he worked on vaccines and small molecules. He has received multiple honors and awards including nationally competitive, recognized fellowships at Merck & Co., Inc., Kenilworth, NJ; DuPont and Mitsubishi. He serves on the boards of the Greater Boston Chamber of Commerce, Massachusetts High Technology Council as Vice Chairman, and is a member of the Advisory Council at Princeton University’s Department of Chemical Engineering.